GBCS · Selectis Health, Inc. · Metrics
$5.73
-0.02 (-0.26%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 24, 2026
The latest filing states the doubt was alleviated.
“As a result of the Company’s historical losses and projected cash needs, substantial doubt exists about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is contingent upon successful execution of management’s plan over the next twelve months to improve the Company’s liquidity and profitability, which includes, without limitation: Increasing revenue by increasing occupancy in the facilities and increasing Medicaid reimbursement rates; Sale of certain facilities; Controlling operating expenses; and Seeking additional capital through the issuance of debt or equity securities, or the sale of assets. The focus on opportunities within the Company’s current portfolio and future properties to acquire and operate, the settlement, refinance, and continued service of debt obligations, the potential funds generated from stock sales and other initiatives contributing to additional working capital should alleviate any substantial doubt about the Company’s ability to continue as a going concern. However, the Company cannot predict, with certainty, the outcome of these actions to generate liquidity and the failure to do so could negatively impact the Company’s future operations.”View the 10-Q filed Aug 24, 2026
Market Cap
$17.57M
Shares
3.07M
Volume · Oct 1
1400
Avg daily vol (3M)
2509
GBCS metrics
25 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$5.73
Market cap
$17.57M
Price action
20 metricsPrice change (1W)
-0.2%
Price change (30D)
-0.2%
Price change (3M)
+10.0%
Price change (6M)
+39.8%
Price change (YTD)
+157.0%
Price change (1Y)
+154.7%
Trailing year
Price change (5Y)
-14.1%
52-week high
$5.83
52-week low
$1.50
Change from 52-week high
-1.7%
Change from 52-week low
+282.0%
Annualized volatility
128.8%
Annualized volatility (3M)
—
Beta
-0.1
RSI (14D)
60.2
Price vs SMA 50
+3.8%
Price vs SMA 200
+69.8%
Avg volume (3M)
2,509
Relative volume
0.6
Average dollar volume
$13,675
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
3.07M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2021-05-26
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—